arrow
S

Shinichiro Uchiyama

international university of health & welfare
H指数:53
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cilostazol Contributes to Risk Reduction of Stroke Recurrence without Mediating a Reduction of Blood Pressure: Results from CSPS.com

西洛他唑通过不介导血压降低的方式,对降低卒中复发风险有贡献:CSPS.com研究的结果

2025-12-010
PRE
Effect of renal function on dual antiplatelet therapy using cilostazol for stroke prevention: a CSPS.com trial post hoc analysis

肾功能对使用西洛他唑进行双联抗血小板治疗预防卒中的影响:CSPS.com试验事后分析

2025-08-180
PRE
Risk of major vascular events in patients without traditional risk factors after transient ischemic attack or minor ischemic stroke: An international prospective cohort

无传统危险因素的患者在短暂性脑缺血发作或轻微缺血性卒中后的主要血管事件风险:一项国际前瞻性队列研究

2024-11-210
OA
Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial
STROKE
IF8.9
2023-03-0110
OA
P2Y12 Reaction Units and Clinical Outcomes in Acute Large Artery Atherosclerotic Stroke: A Multicenter Prospective Study
2023-01-015
OAAI
Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel Subanalysis of the CSPS.com Trial
STROKE
IF8.9
2021-11-0120
OAAI
Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
2021-10-1920
OAAI
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials
2021-10-174
OAAI
Japanese and Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: A Five-Year Risk Analysis of Stroke and Vascular Events

日本和非日本短暂性脑缺血发作或轻度卒中患者: 卒中与血管事件的五年风险分析

2021-06-014
OAAI